Patents by Inventor Randy J. Levitt

Randy J. Levitt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bispecific Oligonucleotide for the Treatment of CNS Malignancies
    Publication number: 20110152354
    Abstract: CNS malignancy is treated in a subject suffering from a CNS malignancy by administering to the subject an antisense oligonucleotide having a sequence of bases that is complementary to portions of both the gene encoding IGFBP-2 and the gene encoding IGFBP-5, and which is of sufficient length to act as an inhibitor of the effective amount of IGFBP-2 and IGFBP-5, in an amount effective to reduce effective levels of IGFBP-2 and IGFBP-5 in cells of the CNS malignancy.
    Type: Application
    Filed: January 11, 2011
    Publication date: June 23, 2011
    Applicant: THE UNIVERSITY OF BRITISH COLUMBIA
    Inventors: Martin E. Gleave, Michael N. Pollak, Randy J. Levitt
  • Bispecific oligonucleotide for the treatment of CNS malignancies
    Patent number: 7932234
    Abstract: CNS malignancy is treated in a subject suffering from a CNS malignancy by administering to the subject an antisense oligonucleotide having a sequence of bases that is complementary to portions of both the gene encoding IGFBP-2 and the gene encoding IGFBP-5, and which is of sufficient length to act as an inhibitor of the effective amount of IGFBP-2 and IGFBP-5, in an amount effective to reduce effective levels of IGFBP-2 and IGFBP-5 in cells of the CNS malignancy.
    Type: Grant
    Filed: May 13, 2005
    Date of Patent: April 26, 2011
    Assignee: The University of British Columbia
    Inventors: Martin E. Gleave, Michael N. Pollak, Randy J. Levitt